nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—ALB—acquired immunodeficiency syndrome	0.144	1	CbGaD
Indomethacin—UGT1A1—Abacavir—acquired immunodeficiency syndrome	0.0396	0.0649	CbGbCtD
Indomethacin—UGT2B7—Zidovudine—acquired immunodeficiency syndrome	0.0214	0.0352	CbGbCtD
Indomethacin—ABCC1—Amprenavir—acquired immunodeficiency syndrome	0.021	0.0344	CbGbCtD
Indomethacin—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.0207	0.034	CbGbCtD
Indomethacin—SLC22A11—Zidovudine—acquired immunodeficiency syndrome	0.0203	0.0334	CbGbCtD
Indomethacin—SLC22A7—Zidovudine—acquired immunodeficiency syndrome	0.0194	0.0318	CbGbCtD
Indomethacin—ABCC3—Lamivudine—acquired immunodeficiency syndrome	0.0192	0.0315	CbGbCtD
Indomethacin—ABCC4—Zidovudine—acquired immunodeficiency syndrome	0.0189	0.0311	CbGbCtD
Indomethacin—ABCC1—Indinavir—acquired immunodeficiency syndrome	0.0181	0.0297	CbGbCtD
Indomethacin—SLCO1A2—Indinavir—acquired immunodeficiency syndrome	0.0161	0.0265	CbGbCtD
Indomethacin—ABCC1—Saquinavir—acquired immunodeficiency syndrome	0.0159	0.0261	CbGbCtD
Indomethacin—ABCC1—Ritonavir—acquired immunodeficiency syndrome	0.0159	0.0261	CbGbCtD
Indomethacin—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.0157	0.0258	CbGbCtD
Indomethacin—SLCO1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0157	0.0257	CbGbCtD
Indomethacin—SLCO1B1—Indinavir—acquired immunodeficiency syndrome	0.0152	0.025	CbGbCtD
Indomethacin—SLCO1B1—Nelfinavir—acquired immunodeficiency syndrome	0.0148	0.0243	CbGbCtD
Indomethacin—ABCC4—Lamivudine—acquired immunodeficiency syndrome	0.0147	0.024	CbGbCtD
Indomethacin—SLCO1A2—Saquinavir—acquired immunodeficiency syndrome	0.0142	0.0233	CbGbCtD
Indomethacin—SLCO1A2—Ritonavir—acquired immunodeficiency syndrome	0.0142	0.0233	CbGbCtD
Indomethacin—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.0134	0.022	CbGbCtD
Indomethacin—SLCO1B1—Saquinavir—acquired immunodeficiency syndrome	0.0134	0.0219	CbGbCtD
Indomethacin—SLCO1B1—Ritonavir—acquired immunodeficiency syndrome	0.0134	0.0219	CbGbCtD
Indomethacin—SLC22A8—Zidovudine—acquired immunodeficiency syndrome	0.0118	0.0194	CbGbCtD
Indomethacin—ABCC1—Lamivudine—acquired immunodeficiency syndrome	0.0118	0.0193	CbGbCtD
Indomethacin—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.0118	0.0193	CbGbCtD
Indomethacin—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.0118	0.0193	CbGbCtD
Indomethacin—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.00872	0.0143	CbGbCtD
Indomethacin—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.00824	0.0135	CbGbCtD
Indomethacin—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.00737	0.0121	CbGbCtD
Indomethacin—ALB—Saquinavir—acquired immunodeficiency syndrome	0.00732	0.012	CbGbCtD
Indomethacin—ALB—Zidovudine—acquired immunodeficiency syndrome	0.00702	0.0115	CbGbCtD
Indomethacin—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.00693	0.0114	CbGbCtD
Indomethacin—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.00638	0.0105	CbGbCtD
Indomethacin—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.00627	0.0103	CbGbCtD
Indomethacin—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.00627	0.0103	CbGbCtD
Indomethacin—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00613	0.0101	CbGbCtD
Indomethacin—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00576	0.00945	CbGbCtD
Indomethacin—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00576	0.00945	CbGbCtD
Indomethacin—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00559	0.00917	CbGbCtD
Indomethacin—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.00541	0.00888	CbGbCtD
Indomethacin—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.00525	0.00862	CbGbCtD
Indomethacin—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00521	0.00855	CbGbCtD
Indomethacin—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00521	0.00855	CbGbCtD
Indomethacin—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00506	0.0083	CbGbCtD
Indomethacin—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00475	0.00779	CbGbCtD
Indomethacin—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00475	0.00779	CbGbCtD
Indomethacin—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00455	0.00747	CbGbCtD
Indomethacin—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0045	0.00738	CbGbCtD
Indomethacin—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00437	0.00716	CbGbCtD
Indomethacin—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00436	0.00716	CbGbCtD
Indomethacin—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00424	0.00695	CbGbCtD
Indomethacin—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00395	0.00648	CbGbCtD
Indomethacin—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00395	0.00648	CbGbCtD
Indomethacin—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00383	0.00629	CbGbCtD
Indomethacin—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00383	0.00629	CbGbCtD
Indomethacin—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00378	0.00621	CbGbCtD
Indomethacin—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00367	0.00603	CbGbCtD
Indomethacin—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00284	0.00466	CbGbCtD
Indomethacin—PLA2G2A—blood plasma—acquired immunodeficiency syndrome	0.00142	0.022	CbGeAlD
Indomethacin—ABCC6—blood plasma—acquired immunodeficiency syndrome	0.0014	0.0217	CbGeAlD
Indomethacin—PTGDR2—blood—acquired immunodeficiency syndrome	0.00136	0.0211	CbGeAlD
Indomethacin—PPARA—blood plasma—acquired immunodeficiency syndrome	0.00132	0.0205	CbGeAlD
Indomethacin—UGT1A1—blood plasma—acquired immunodeficiency syndrome	0.00102	0.0157	CbGeAlD
Indomethacin—PTGR2—blood—acquired immunodeficiency syndrome	0.000905	0.014	CbGeAlD
Indomethacin—PTGR2—spinal cord—acquired immunodeficiency syndrome	0.000872	0.0135	CbGeAlD
Indomethacin—PTGDR2—brain—acquired immunodeficiency syndrome	0.000846	0.0131	CbGeAlD
Indomethacin—SLCO1B1—blood plasma—acquired immunodeficiency syndrome	0.000845	0.0131	CbGeAlD
Indomethacin—PTGR2—vagina—acquired immunodeficiency syndrome	0.000839	0.013	CbGeAlD
Indomethacin—GLO1—retina—acquired immunodeficiency syndrome	0.000836	0.0129	CbGeAlD
Indomethacin—PPARG—endothelium—acquired immunodeficiency syndrome	0.00082	0.0127	CbGeAlD
Indomethacin—ABCC3—blood plasma—acquired immunodeficiency syndrome	0.000802	0.0124	CbGeAlD
Indomethacin—PTGR2—lung—acquired immunodeficiency syndrome	0.000793	0.0123	CbGeAlD
Indomethacin—ABCC6—retina—acquired immunodeficiency syndrome	0.000769	0.0119	CbGeAlD
Indomethacin—PTGR2—nervous system—acquired immunodeficiency syndrome	0.000734	0.0114	CbGeAlD
Indomethacin—GLO1—skin of body—acquired immunodeficiency syndrome	0.000734	0.0114	CbGeAlD
Indomethacin—PPARG—blood plasma—acquired immunodeficiency syndrome	0.000729	0.0113	CbGeAlD
Indomethacin—PPARA—retina—acquired immunodeficiency syndrome	0.000726	0.0112	CbGeAlD
Indomethacin—PTGR2—central nervous system—acquired immunodeficiency syndrome	0.000707	0.011	CbGeAlD
Indomethacin—ABCC4—blood plasma—acquired immunodeficiency syndrome	0.000662	0.0102	CbGeAlD
Indomethacin—PPARA—skin of body—acquired immunodeficiency syndrome	0.000637	0.00986	CbGeAlD
Indomethacin—GLO1—lymphoid tissue—acquired immunodeficiency syndrome	0.000594	0.0092	CbGeAlD
Indomethacin—GLO1—digestive system—acquired immunodeficiency syndrome	0.000587	0.00909	CbGeAlD
Indomethacin—UGT1A9—digestive system—acquired immunodeficiency syndrome	0.00057	0.00882	CbGeAlD
Indomethacin—PTGR2—brain—acquired immunodeficiency syndrome	0.000561	0.00869	CbGeAlD
Indomethacin—GLO1—blood—acquired immunodeficiency syndrome	0.000559	0.00866	CbGeAlD
Indomethacin—PLA2G2A—lymphoid tissue—acquired immunodeficiency syndrome	0.000552	0.00855	CbGeAlD
Indomethacin—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00055	0.00852	CbGeAlD
Indomethacin—PLA2G2A—digestive system—acquired immunodeficiency syndrome	0.000545	0.00845	CbGeAlD
Indomethacin—PTGR2—lymph node—acquired immunodeficiency syndrome	0.000542	0.0084	CbGeAlD
Indomethacin—GLO1—bone marrow—acquired immunodeficiency syndrome	0.000541	0.00838	CbGeAlD
Indomethacin—GLO1—spinal cord—acquired immunodeficiency syndrome	0.000539	0.00834	CbGeAlD
Indomethacin—PLA2G2A—blood—acquired immunodeficiency syndrome	0.00052	0.00805	CbGeAlD
Indomethacin—GLO1—vagina—acquired immunodeficiency syndrome	0.000518	0.00802	CbGeAlD
Indomethacin—PPARA—lymphoid tissue—acquired immunodeficiency syndrome	0.000516	0.00799	CbGeAlD
Indomethacin—CXCL8—blood—acquired immunodeficiency syndrome	0.000514	0.00797	CbGeAlD
Indomethacin—ABCC6—blood—acquired immunodeficiency syndrome	0.000514	0.00797	CbGeAlD
Indomethacin—PPARA—digestive system—acquired immunodeficiency syndrome	0.00051	0.00789	CbGeAlD
Indomethacin—CXCL8—bone marrow—acquired immunodeficiency syndrome	0.000498	0.00771	CbGeAlD
Indomethacin—CXCL8—spinal cord—acquired immunodeficiency syndrome	0.000496	0.00768	CbGeAlD
Indomethacin—GLO1—lung—acquired immunodeficiency syndrome	0.00049	0.00759	CbGeAlD
Indomethacin—SLC10A1—digestive system—acquired immunodeficiency syndrome	0.00049	0.00759	CbGeAlD
Indomethacin—PPARA—blood—acquired immunodeficiency syndrome	0.000485	0.00752	CbGeAlD
Indomethacin—CXCL8—vagina—acquired immunodeficiency syndrome	0.000477	0.00738	CbGeAlD
Indomethacin—UGT2B7—digestive system—acquired immunodeficiency syndrome	0.000459	0.00711	CbGeAlD
Indomethacin—PLA2G2A—lung—acquired immunodeficiency syndrome	0.000456	0.00705	CbGeAlD
Indomethacin—GLO1—nervous system—acquired immunodeficiency syndrome	0.000454	0.00703	CbGeAlD
Indomethacin—ABCC6—lung—acquired immunodeficiency syndrome	0.000451	0.00698	CbGeAlD
Indomethacin—CXCL8—lung—acquired immunodeficiency syndrome	0.000451	0.00698	CbGeAlD
Indomethacin—SLC22A11—digestive system—acquired immunodeficiency syndrome	0.000447	0.00693	CbGeAlD
Indomethacin—PTGS1—endothelium—acquired immunodeficiency syndrome	0.000439	0.00679	CbGeAlD
Indomethacin—GLO1—central nervous system—acquired immunodeficiency syndrome	0.000437	0.00677	CbGeAlD
Indomethacin—SLC22A7—digestive system—acquired immunodeficiency syndrome	0.000437	0.00676	CbGeAlD
Indomethacin—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000427	0.00661	CbGeAlD
Indomethacin—PPARA—lung—acquired immunodeficiency syndrome	0.000426	0.00659	CbGeAlD
Indomethacin—PLA2G2A—nervous system—acquired immunodeficiency syndrome	0.000422	0.00653	CbGeAlD
Indomethacin—PTGS2—endothelium—acquired immunodeficiency syndrome	0.000419	0.00649	CbGeAlD
Indomethacin—PLA2G2A—central nervous system—acquired immunodeficiency syndrome	0.000406	0.00629	CbGeAlD
Indomethacin—AKR1C3—blood—acquired immunodeficiency syndrome	0.000403	0.00625	CbGeAlD
Indomethacin—PPARA—nervous system—acquired immunodeficiency syndrome	0.000394	0.0061	CbGeAlD
Indomethacin—UGT1A1—digestive system—acquired immunodeficiency syndrome	0.00039	0.00605	CbGeAlD
Indomethacin—AKR1C3—bone marrow—acquired immunodeficiency syndrome	0.00039	0.00604	CbGeAlD
Indomethacin—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.00039	0.00603	CbGeAlD
Indomethacin—AKR1C3—spinal cord—acquired immunodeficiency syndrome	0.000389	0.00602	CbGeAlD
Indomethacin—CES1—lymphoid tissue—acquired immunodeficiency syndrome	0.000383	0.00593	CbGeAlD
Indomethacin—PPARA—central nervous system—acquired immunodeficiency syndrome	0.000379	0.00588	CbGeAlD
Indomethacin—SLC10A1—nervous system—acquired immunodeficiency syndrome	0.000379	0.00587	CbGeAlD
Indomethacin—CES1—digestive system—acquired immunodeficiency syndrome	0.000378	0.00586	CbGeAlD
Indomethacin—AKR1C3—vagina—acquired immunodeficiency syndrome	0.000374	0.00579	CbGeAlD
Indomethacin—PTGS2—blood plasma—acquired immunodeficiency syndrome	0.000372	0.00577	CbGeAlD
Indomethacin—UGT1A1—blood—acquired immunodeficiency syndrome	0.000372	0.00576	CbGeAlD
Indomethacin—SLC10A1—central nervous system—acquired immunodeficiency syndrome	0.000365	0.00565	CbGeAlD
Indomethacin—CES1—blood—acquired immunodeficiency syndrome	0.00036	0.00558	CbGeAlD
Indomethacin—AKR1C3—lung—acquired immunodeficiency syndrome	0.000354	0.00548	CbGeAlD
Indomethacin—PPARG—skin of body—acquired immunodeficiency syndrome	0.00035	0.00542	CbGeAlD
Indomethacin—GLO1—brain—acquired immunodeficiency syndrome	0.000347	0.00537	CbGeAlD
Indomethacin—GLO1—lymph node—acquired immunodeficiency syndrome	0.000335	0.00519	CbGeAlD
Indomethacin—SLCO1B1—digestive system—acquired immunodeficiency syndrome	0.000325	0.00503	CbGeAlD
Indomethacin—PLA2G2A—brain—acquired immunodeficiency syndrome	0.000322	0.00499	CbGeAlD
Indomethacin—CXCL8—brain—acquired immunodeficiency syndrome	0.000319	0.00494	CbGeAlD
Indomethacin—CES1—lung—acquired immunodeficiency syndrome	0.000316	0.00489	CbGeAlD
Indomethacin—PLA2G2A—lymph node—acquired immunodeficiency syndrome	0.000312	0.00483	CbGeAlD
Indomethacin—SLCO1B1—blood—acquired immunodeficiency syndrome	0.000309	0.00479	CbGeAlD
Indomethacin—CXCL8—lymph node—acquired immunodeficiency syndrome	0.000308	0.00478	CbGeAlD
Indomethacin—ABCC3—digestive system—acquired immunodeficiency syndrome	0.000308	0.00477	CbGeAlD
Indomethacin—PPARA—brain—acquired immunodeficiency syndrome	0.000301	0.00466	CbGeAlD
Indomethacin—ABCC3—blood—acquired immunodeficiency syndrome	0.000294	0.00455	CbGeAlD
Indomethacin—CES1—nervous system—acquired immunodeficiency syndrome	0.000292	0.00453	CbGeAlD
Indomethacin—PPARA—lymph node—acquired immunodeficiency syndrome	0.000291	0.00451	CbGeAlD
Indomethacin—SLC10A1—brain—acquired immunodeficiency syndrome	0.00029	0.00449	CbGeAlD
Indomethacin—PPARG—lymphoid tissue—acquired immunodeficiency syndrome	0.000284	0.00439	CbGeAlD
Indomethacin—CES1—central nervous system—acquired immunodeficiency syndrome	0.000282	0.00436	CbGeAlD
Indomethacin—PPARG—digestive system—acquired immunodeficiency syndrome	0.00028	0.00434	CbGeAlD
Indomethacin—PPARG—blood—acquired immunodeficiency syndrome	0.000267	0.00413	CbGeAlD
Indomethacin—SLCO1A2—digestive system—acquired immunodeficiency syndrome	0.000264	0.00409	CbGeAlD
Indomethacin—PPARG—bone marrow—acquired immunodeficiency syndrome	0.000258	0.004	CbGeAlD
Indomethacin—SLC22A7—brain—acquired immunodeficiency syndrome	0.000258	0.004	CbGeAlD
Indomethacin—ABCC3—lung—acquired immunodeficiency syndrome	0.000257	0.00399	CbGeAlD
Indomethacin—ABCC4—digestive system—acquired immunodeficiency syndrome	0.000254	0.00394	CbGeAlD
Indomethacin—AKR1C3—brain—acquired immunodeficiency syndrome	0.00025	0.00388	CbGeAlD
Indomethacin—SLC22A6—brain—acquired immunodeficiency syndrome	0.000249	0.00386	CbGeAlD
Indomethacin—PPARG—vagina—acquired immunodeficiency syndrome	0.000247	0.00383	CbGeAlD
Indomethacin—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000246	0.00381	CbGeAlD
Indomethacin—SLCO1A2—spinal cord—acquired immunodeficiency syndrome	0.000243	0.00376	CbGeAlD
Indomethacin—ABCC4—blood—acquired immunodeficiency syndrome	0.000242	0.00375	CbGeAlD
Indomethacin—AKR1C3—lymph node—acquired immunodeficiency syndrome	0.000242	0.00374	CbGeAlD
Indomethacin—SLC22A8—blood—acquired immunodeficiency syndrome	0.00024	0.00372	CbGeAlD
Indomethacin—ABCC3—nervous system—acquired immunodeficiency syndrome	0.000238	0.00369	CbGeAlD
Indomethacin—ABCC2—blood—acquired immunodeficiency syndrome	0.000235	0.00363	CbGeAlD
Indomethacin—ABCC4—bone marrow—acquired immunodeficiency syndrome	0.000235	0.00363	CbGeAlD
Indomethacin—PPARG—lung—acquired immunodeficiency syndrome	0.000234	0.00362	CbGeAlD
Indomethacin—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.00023	0.00357	CbGeAlD
Indomethacin—ABCC3—central nervous system—acquired immunodeficiency syndrome	0.000229	0.00355	CbGeAlD
Indomethacin—CES1—brain—acquired immunodeficiency syndrome	0.000224	0.00346	CbGeAlD
Indomethacin—SLCO1A2—lung—acquired immunodeficiency syndrome	0.000221	0.00342	CbGeAlD
Indomethacin—PPARG—nervous system—acquired immunodeficiency syndrome	0.000217	0.00336	CbGeAlD
Indomethacin—CES1—lymph node—acquired immunodeficiency syndrome	0.000216	0.00334	CbGeAlD
Indomethacin—ABCC4—lung—acquired immunodeficiency syndrome	0.000212	0.00329	CbGeAlD
Indomethacin—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000212	0.00328	CbGeAlD
Indomethacin—PPARG—central nervous system—acquired immunodeficiency syndrome	0.000209	0.00323	CbGeAlD
Indomethacin—ABCC1—blood—acquired immunodeficiency syndrome	0.000207	0.0032	CbGeAlD
Indomethacin—SLCO1A2—nervous system—acquired immunodeficiency syndrome	0.000204	0.00317	CbGeAlD
Indomethacin—CYP2C19—blood—acquired immunodeficiency syndrome	0.000202	0.00312	CbGeAlD
Indomethacin—SLCO1A2—central nervous system—acquired immunodeficiency syndrome	0.000197	0.00305	CbGeAlD
Indomethacin—ABCC4—nervous system—acquired immunodeficiency syndrome	0.000197	0.00305	CbGeAlD
Indomethacin—SLC22A8—nervous system—acquired immunodeficiency syndrome	0.000195	0.00302	CbGeAlD
Indomethacin—ABCC1—vagina—acquired immunodeficiency syndrome	0.000192	0.00297	CbGeAlD
Indomethacin—ABCC4—central nervous system—acquired immunodeficiency syndrome	0.000189	0.00293	CbGeAlD
Indomethacin—SLC22A8—central nervous system—acquired immunodeficiency syndrome	0.000188	0.00291	CbGeAlD
Indomethacin—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000187	0.0029	CbGeAlD
Indomethacin—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000187	0.00289	CbGeAlD
Indomethacin—ABCC3—brain—acquired immunodeficiency syndrome	0.000182	0.00282	CbGeAlD
Indomethacin—ABCC1—lung—acquired immunodeficiency syndrome	0.000181	0.00281	CbGeAlD
Indomethacin—PTGS2—skin of body—acquired immunodeficiency syndrome	0.000179	0.00277	CbGeAlD
Indomethacin—ABCC3—lymph node—acquired immunodeficiency syndrome	0.000176	0.00273	CbGeAlD
Indomethacin—PPARG—brain—acquired immunodeficiency syndrome	0.000166	0.00256	CbGeAlD
Indomethacin—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000164	0.00254	CbGeAlD
Indomethacin—PPARG—lymph node—acquired immunodeficiency syndrome	0.00016	0.00248	CbGeAlD
Indomethacin—CYP2C9—blood—acquired immunodeficiency syndrome	0.000156	0.00242	CbGeAlD
Indomethacin—SLCO1A2—brain—acquired immunodeficiency syndrome	0.000156	0.00242	CbGeAlD
Indomethacin—ALB—brain—acquired immunodeficiency syndrome	0.000155	0.00241	CbGeAlD
Indomethacin—ABCC4—brain—acquired immunodeficiency syndrome	0.00015	0.00233	CbGeAlD
Indomethacin—ALB—lymph node—acquired immunodeficiency syndrome	0.00015	0.00232	CbGeAlD
Indomethacin—PTGS1—digestive system—acquired immunodeficiency syndrome	0.00015	0.00232	CbGeAlD
Indomethacin—SLC22A8—brain—acquired immunodeficiency syndrome	0.000149	0.00231	CbGeAlD
Indomethacin—ABCC4—lymph node—acquired immunodeficiency syndrome	0.000145	0.00225	CbGeAlD
Indomethacin—PTGS2—lymphoid tissue—acquired immunodeficiency syndrome	0.000145	0.00224	CbGeAlD
Indomethacin—PTGS2—digestive system—acquired immunodeficiency syndrome	0.000143	0.00222	CbGeAlD
Indomethacin—PTGS1—blood—acquired immunodeficiency syndrome	0.000143	0.00221	CbGeAlD
Indomethacin—ABCC2—lymph node—acquired immunodeficiency syndrome	0.000141	0.00218	CbGeAlD
Indomethacin—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000137	0.00213	CbGeAlD
Indomethacin—PTGS2—blood—acquired immunodeficiency syndrome	0.000136	0.00211	CbGeAlD
Indomethacin—PTGS1—vagina—acquired immunodeficiency syndrome	0.000132	0.00205	CbGeAlD
Indomethacin—PTGS2—bone marrow—acquired immunodeficiency syndrome	0.000132	0.00204	CbGeAlD
Indomethacin—PTGS2—spinal cord—acquired immunodeficiency syndrome	0.000131	0.00204	CbGeAlD
Indomethacin—ABCC1—brain—acquired immunodeficiency syndrome	0.000128	0.00199	CbGeAlD
Indomethacin—PTGS2—vagina—acquired immunodeficiency syndrome	0.000126	0.00196	CbGeAlD
Indomethacin—ABCB1—retina—acquired immunodeficiency syndrome	0.000126	0.00195	CbGeAlD
Indomethacin—PTGS1—lung—acquired immunodeficiency syndrome	0.000125	0.00194	CbGeAlD
Indomethacin—ABCC1—lymph node—acquired immunodeficiency syndrome	0.000124	0.00192	CbGeAlD
Indomethacin—PTGS2—lung—acquired immunodeficiency syndrome	0.00012	0.00185	CbGeAlD
Indomethacin—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000116	0.00179	CbGeAlD
Indomethacin—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000112	0.00173	CbGeAlD
Indomethacin—PTGS2—nervous system—acquired immunodeficiency syndrome	0.000111	0.00171	CbGeAlD
Indomethacin—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000108	0.000765	CcSEcCtD
Indomethacin—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000108	0.000765	CcSEcCtD
Indomethacin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000108	0.000765	CcSEcCtD
Indomethacin—Headache—Didanosine—acquired immunodeficiency syndrome	0.000107	0.000761	CcSEcCtD
Indomethacin—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000107	0.00076	CcSEcCtD
Indomethacin—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000107	0.000759	CcSEcCtD
Indomethacin—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000758	CcSEcCtD
Indomethacin—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000758	CcSEcCtD
Indomethacin—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000107	0.000758	CcSEcCtD
Indomethacin—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000107	0.000757	CcSEcCtD
Indomethacin—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000757	CcSEcCtD
Indomethacin—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000107	0.000755	CcSEcCtD
Indomethacin—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000755	CcSEcCtD
Indomethacin—PTGS2—central nervous system—acquired immunodeficiency syndrome	0.000107	0.00165	CbGeAlD
Indomethacin—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000755	CcSEcCtD
Indomethacin—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.000754	CcSEcCtD
Indomethacin—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000754	CcSEcCtD
Indomethacin—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000752	CcSEcCtD
Indomethacin—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000752	CcSEcCtD
Indomethacin—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000106	0.00075	CcSEcCtD
Indomethacin—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000106	0.00075	CcSEcCtD
Indomethacin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000106	0.000748	CcSEcCtD
Indomethacin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000106	0.000747	CcSEcCtD
Indomethacin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000105	0.000746	CcSEcCtD
Indomethacin—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000105	0.000745	CcSEcCtD
Indomethacin—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000745	CcSEcCtD
Indomethacin—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000744	CcSEcCtD
Indomethacin—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000743	CcSEcCtD
Indomethacin—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000105	0.000741	CcSEcCtD
Indomethacin—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000741	CcSEcCtD
Indomethacin—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000741	CcSEcCtD
Indomethacin—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000739	CcSEcCtD
Indomethacin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000104	0.000735	CcSEcCtD
Indomethacin—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000735	CcSEcCtD
Indomethacin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.000735	CcSEcCtD
Indomethacin—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000734	CcSEcCtD
Indomethacin—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000733	CcSEcCtD
Indomethacin—Pain—Indinavir—acquired immunodeficiency syndrome	0.000103	0.000729	CcSEcCtD
Indomethacin—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000103	0.000729	CcSEcCtD
Indomethacin—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000103	0.000728	CcSEcCtD
Indomethacin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000103	0.000728	CcSEcCtD
Indomethacin—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000728	CcSEcCtD
Indomethacin—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000726	CcSEcCtD
Indomethacin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000102	0.000725	CcSEcCtD
Indomethacin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000102	0.000725	CcSEcCtD
Indomethacin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000102	0.000724	CcSEcCtD
Indomethacin—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.000723	CcSEcCtD
Indomethacin—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000723	CcSEcCtD
Indomethacin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000102	0.000722	CcSEcCtD
Indomethacin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000102	0.000722	CcSEcCtD
Indomethacin—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.00072	CcSEcCtD
Indomethacin—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.00072	CcSEcCtD
Indomethacin—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000719	CcSEcCtD
Indomethacin—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000719	CcSEcCtD
Indomethacin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000101	0.000718	CcSEcCtD
Indomethacin—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000718	CcSEcCtD
Indomethacin—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000101	0.000716	CcSEcCtD
Indomethacin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000715	CcSEcCtD
Indomethacin—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000713	CcSEcCtD
Indomethacin—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000713	CcSEcCtD
Indomethacin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.0001	0.000711	CcSEcCtD
Indomethacin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.0001	0.000709	CcSEcCtD
Indomethacin—Discomfort—Saquinavir—acquired immunodeficiency syndrome	9.98e-05	0.000707	CcSEcCtD
Indomethacin—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	9.95e-05	0.000705	CcSEcCtD
Indomethacin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	9.92e-05	0.000702	CcSEcCtD
Indomethacin—Shock—Ritonavir—acquired immunodeficiency syndrome	9.9e-05	0.000701	CcSEcCtD
Indomethacin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	9.89e-05	0.0007	CcSEcCtD
Indomethacin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	9.88e-05	0.0007	CcSEcCtD
Indomethacin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	9.85e-05	0.000698	CcSEcCtD
Indomethacin—Dizziness—Stavudine—acquired immunodeficiency syndrome	9.85e-05	0.000697	CcSEcCtD
Indomethacin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	9.84e-05	0.000697	CcSEcCtD
Indomethacin—Insomnia—Delavirdine—acquired immunodeficiency syndrome	9.84e-05	0.000697	CcSEcCtD
Indomethacin—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	9.82e-05	0.000695	CcSEcCtD
Indomethacin—Convulsion—Lamivudine—acquired immunodeficiency syndrome	9.81e-05	0.000695	CcSEcCtD
Indomethacin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	9.81e-05	0.000694	CcSEcCtD
Indomethacin—Fatigue—Efavirenz—acquired immunodeficiency syndrome	9.81e-05	0.000694	CcSEcCtD
Indomethacin—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	9.77e-05	0.000692	CcSEcCtD
Indomethacin—Confusional state—Saquinavir—acquired immunodeficiency syndrome	9.77e-05	0.000692	CcSEcCtD
Indomethacin—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	9.73e-05	0.000689	CcSEcCtD
Indomethacin—Constipation—Efavirenz—acquired immunodeficiency syndrome	9.73e-05	0.000689	CcSEcCtD
Indomethacin—Pain—Efavirenz—acquired immunodeficiency syndrome	9.73e-05	0.000689	CcSEcCtD
Indomethacin—Rash—Nevirapine—acquired immunodeficiency syndrome	9.72e-05	0.000689	CcSEcCtD
Indomethacin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	9.72e-05	0.000688	CcSEcCtD
Indomethacin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	9.7e-05	0.000687	CcSEcCtD
Indomethacin—Dizziness—Abacavir—acquired immunodeficiency syndrome	9.7e-05	0.000687	CcSEcCtD
Indomethacin—Oedema—Saquinavir—acquired immunodeficiency syndrome	9.69e-05	0.000686	CcSEcCtD
Indomethacin—Somnolence—Delavirdine—acquired immunodeficiency syndrome	9.67e-05	0.000685	CcSEcCtD
Indomethacin—Headache—Nevirapine—acquired immunodeficiency syndrome	9.66e-05	0.000684	CcSEcCtD
Indomethacin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	9.64e-05	0.000683	CcSEcCtD
Indomethacin—Anxiety—Lamivudine—acquired immunodeficiency syndrome	9.61e-05	0.00068	CcSEcCtD
Indomethacin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	9.59e-05	0.000679	CcSEcCtD
Indomethacin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	9.58e-05	0.000678	CcSEcCtD
Indomethacin—Urticaria—Indinavir—acquired immunodeficiency syndrome	9.56e-05	0.000677	CcSEcCtD
Indomethacin—Shock—Saquinavir—acquired immunodeficiency syndrome	9.53e-05	0.000675	CcSEcCtD
Indomethacin—Discomfort—Lamivudine—acquired immunodeficiency syndrome	9.52e-05	0.000674	CcSEcCtD
Indomethacin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	9.52e-05	0.000674	CcSEcCtD
Indomethacin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	9.52e-05	0.000674	CcSEcCtD
Indomethacin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	9.5e-05	0.000673	CcSEcCtD
Indomethacin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	9.48e-05	0.000672	CcSEcCtD
Indomethacin—Vomiting—Stavudine—acquired immunodeficiency syndrome	9.47e-05	0.000671	CcSEcCtD
Indomethacin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	9.46e-05	0.00067	CcSEcCtD
Indomethacin—Rash—Nelfinavir—acquired immunodeficiency syndrome	9.42e-05	0.000667	CcSEcCtD
Indomethacin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	9.41e-05	0.000666	CcSEcCtD
Indomethacin—Hypotension—Ritonavir—acquired immunodeficiency syndrome	9.4e-05	0.000666	CcSEcCtD
Indomethacin—Rash—Stavudine—acquired immunodeficiency syndrome	9.39e-05	0.000665	CcSEcCtD
Indomethacin—Fatigue—Delavirdine—acquired immunodeficiency syndrome	9.38e-05	0.000664	CcSEcCtD
Indomethacin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	9.38e-05	0.000664	CcSEcCtD
Indomethacin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	9.37e-05	0.000664	CcSEcCtD
Indomethacin—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	9.36e-05	0.000663	CcSEcCtD
Indomethacin—Headache—Nelfinavir—acquired immunodeficiency syndrome	9.36e-05	0.000663	CcSEcCtD
Indomethacin—Headache—Stavudine—acquired immunodeficiency syndrome	9.33e-05	0.000661	CcSEcCtD
Indomethacin—Vomiting—Abacavir—acquired immunodeficiency syndrome	9.33e-05	0.000661	CcSEcCtD
Indomethacin—Confusional state—Lamivudine—acquired immunodeficiency syndrome	9.32e-05	0.00066	CcSEcCtD
Indomethacin—Pain—Delavirdine—acquired immunodeficiency syndrome	9.31e-05	0.000659	CcSEcCtD
Indomethacin—Constipation—Delavirdine—acquired immunodeficiency syndrome	9.31e-05	0.000659	CcSEcCtD
Indomethacin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	9.3e-05	0.000659	CcSEcCtD
Indomethacin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	9.29e-05	0.000658	CcSEcCtD
Indomethacin—Rash—Abacavir—acquired immunodeficiency syndrome	9.25e-05	0.000655	CcSEcCtD
Indomethacin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	9.24e-05	0.000654	CcSEcCtD
Indomethacin—Oedema—Lamivudine—acquired immunodeficiency syndrome	9.24e-05	0.000654	CcSEcCtD
Indomethacin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	9.24e-05	0.000654	CcSEcCtD
Indomethacin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	9.23e-05	0.000654	CcSEcCtD
Indomethacin—Headache—Abacavir—acquired immunodeficiency syndrome	9.19e-05	0.000651	CcSEcCtD
Indomethacin—Nausea—Nevirapine—acquired immunodeficiency syndrome	9.16e-05	0.000649	CcSEcCtD
Indomethacin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	9.16e-05	0.000648	CcSEcCtD
Indomethacin—Insomnia—Ritonavir—acquired immunodeficiency syndrome	9.1e-05	0.000645	CcSEcCtD
Indomethacin—Shock—Lamivudine—acquired immunodeficiency syndrome	9.09e-05	0.000644	CcSEcCtD
Indomethacin—Hypotension—Saquinavir—acquired immunodeficiency syndrome	9.05e-05	0.000641	CcSEcCtD
Indomethacin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	9.05e-05	0.000641	CcSEcCtD
Indomethacin—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	9.04e-05	0.00064	CcSEcCtD
Indomethacin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	9.04e-05	0.00064	CcSEcCtD
Indomethacin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	8.99e-05	0.000637	CcSEcCtD
Indomethacin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	8.99e-05	0.000637	CcSEcCtD
Indomethacin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	8.97e-05	0.000635	CcSEcCtD
Indomethacin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	8.97e-05	0.000635	CcSEcCtD
Indomethacin—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	8.97e-05	0.00139	CbGeAlD
Indomethacin—Somnolence—Ritonavir—acquired immunodeficiency syndrome	8.95e-05	0.000634	CcSEcCtD
Indomethacin—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	8.93e-05	0.000633	CcSEcCtD
Indomethacin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	8.9e-05	0.00063	CcSEcCtD
Indomethacin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	8.87e-05	0.000628	CcSEcCtD
Indomethacin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	8.87e-05	0.000628	CcSEcCtD
Indomethacin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	8.86e-05	0.000627	CcSEcCtD
Indomethacin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	8.86e-05	0.000627	CcSEcCtD
Indomethacin—ABCB1—digestive system—acquired immunodeficiency syndrome	8.86e-05	0.00137	CbGeAlD
Indomethacin—PTGS1—brain—acquired immunodeficiency syndrome	8.85e-05	0.00137	CbGeAlD
Indomethacin—Nausea—Stavudine—acquired immunodeficiency syndrome	8.85e-05	0.000626	CcSEcCtD
Indomethacin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	8.81e-05	0.000624	CcSEcCtD
Indomethacin—Insomnia—Saquinavir—acquired immunodeficiency syndrome	8.76e-05	0.00062	CcSEcCtD
Indomethacin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	8.75e-05	0.000619	CcSEcCtD
Indomethacin—Nausea—Abacavir—acquired immunodeficiency syndrome	8.71e-05	0.000617	CcSEcCtD
Indomethacin—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	8.7e-05	0.000616	CcSEcCtD
Indomethacin—Fatigue—Ritonavir—acquired immunodeficiency syndrome	8.68e-05	0.000614	CcSEcCtD
Indomethacin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	8.64e-05	0.000612	CcSEcCtD
Indomethacin—Asthenia—Indinavir—acquired immunodeficiency syndrome	8.64e-05	0.000612	CcSEcCtD
Indomethacin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	8.63e-05	0.000611	CcSEcCtD
Indomethacin—Hypotension—Lamivudine—acquired immunodeficiency syndrome	8.63e-05	0.000611	CcSEcCtD
Indomethacin—Somnolence—Saquinavir—acquired immunodeficiency syndrome	8.61e-05	0.00061	CcSEcCtD
Indomethacin—Pain—Ritonavir—acquired immunodeficiency syndrome	8.61e-05	0.000609	CcSEcCtD
Indomethacin—Constipation—Ritonavir—acquired immunodeficiency syndrome	8.61e-05	0.000609	CcSEcCtD
Indomethacin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	8.6e-05	0.000609	CcSEcCtD
Indomethacin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	8.6e-05	0.000609	CcSEcCtD
Indomethacin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	8.56e-05	0.000606	CcSEcCtD
Indomethacin—PTGS1—lymph node—acquired immunodeficiency syndrome	8.56e-05	0.00132	CbGeAlD
Indomethacin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	8.53e-05	0.000604	CcSEcCtD
Indomethacin—Pruritus—Indinavir—acquired immunodeficiency syndrome	8.52e-05	0.000603	CcSEcCtD
Indomethacin—PTGS2—brain—acquired immunodeficiency syndrome	8.46e-05	0.00131	CbGeAlD
Indomethacin—ABCB1—blood—acquired immunodeficiency syndrome	8.44e-05	0.00131	CbGeAlD
Indomethacin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	8.42e-05	0.000596	CcSEcCtD
Indomethacin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	8.38e-05	0.000593	CcSEcCtD
Indomethacin—Insomnia—Lamivudine—acquired immunodeficiency syndrome	8.36e-05	0.000592	CcSEcCtD
Indomethacin—Fatigue—Saquinavir—acquired immunodeficiency syndrome	8.35e-05	0.000591	CcSEcCtD
Indomethacin—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	8.3e-05	0.000588	CcSEcCtD
Indomethacin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	8.29e-05	0.000587	CcSEcCtD
Indomethacin—Pain—Saquinavir—acquired immunodeficiency syndrome	8.28e-05	0.000587	CcSEcCtD
Indomethacin—Constipation—Saquinavir—acquired immunodeficiency syndrome	8.28e-05	0.000587	CcSEcCtD
Indomethacin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	8.24e-05	0.000583	CcSEcCtD
Indomethacin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	8.24e-05	0.000583	CcSEcCtD
Indomethacin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	8.23e-05	0.000583	CcSEcCtD
Indomethacin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	8.23e-05	0.000583	CcSEcCtD
Indomethacin—Somnolence—Lamivudine—acquired immunodeficiency syndrome	8.21e-05	0.000582	CcSEcCtD
Indomethacin—PTGS2—lymph node—acquired immunodeficiency syndrome	8.18e-05	0.00127	CbGeAlD
Indomethacin—ABCB1—bone marrow—acquired immunodeficiency syndrome	8.16e-05	0.00126	CbGeAlD
Indomethacin—Rash—Zidovudine—acquired immunodeficiency syndrome	8.16e-05	0.000578	CcSEcCtD
Indomethacin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	8.16e-05	0.000578	CcSEcCtD
Indomethacin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	8.15e-05	0.000577	CcSEcCtD
Indomethacin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	8.13e-05	0.000576	CcSEcCtD
Indomethacin—ABCB1—spinal cord—acquired immunodeficiency syndrome	8.13e-05	0.00126	CbGeAlD
Indomethacin—Headache—Zidovudine—acquired immunodeficiency syndrome	8.11e-05	0.000574	CcSEcCtD
Indomethacin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	8.05e-05	0.00057	CcSEcCtD
Indomethacin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	8.03e-05	0.000569	CcSEcCtD
Indomethacin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	8.02e-05	0.000568	CcSEcCtD
Indomethacin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	7.99e-05	0.000566	CcSEcCtD
Indomethacin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	7.98e-05	0.000565	CcSEcCtD
Indomethacin—Fatigue—Lamivudine—acquired immunodeficiency syndrome	7.97e-05	0.000564	CcSEcCtD
Indomethacin—Dizziness—Indinavir—acquired immunodeficiency syndrome	7.96e-05	0.000564	CcSEcCtD
Indomethacin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	7.95e-05	0.000563	CcSEcCtD
Indomethacin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	7.95e-05	0.000563	CcSEcCtD
Indomethacin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	7.92e-05	0.000561	CcSEcCtD
Indomethacin—Pain—Lamivudine—acquired immunodeficiency syndrome	7.9e-05	0.00056	CcSEcCtD
Indomethacin—Constipation—Lamivudine—acquired immunodeficiency syndrome	7.9e-05	0.00056	CcSEcCtD
Indomethacin—ABCB1—vagina—acquired immunodeficiency syndrome	7.82e-05	0.00121	CbGeAlD
Indomethacin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	7.81e-05	0.000553	CcSEcCtD
Indomethacin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	7.78e-05	0.000551	CcSEcCtD
Indomethacin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	7.7e-05	0.000545	CcSEcCtD
Indomethacin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	7.69e-05	0.000545	CcSEcCtD
Indomethacin—Nausea—Zidovudine—acquired immunodeficiency syndrome	7.69e-05	0.000544	CcSEcCtD
Indomethacin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	7.66e-05	0.000542	CcSEcCtD
Indomethacin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	7.66e-05	0.000542	CcSEcCtD
Indomethacin—Vomiting—Indinavir—acquired immunodeficiency syndrome	7.65e-05	0.000542	CcSEcCtD
Indomethacin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	7.61e-05	0.000539	CcSEcCtD
Indomethacin—Rash—Indinavir—acquired immunodeficiency syndrome	7.59e-05	0.000537	CcSEcCtD
Indomethacin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	7.58e-05	0.000537	CcSEcCtD
Indomethacin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	7.56e-05	0.000535	CcSEcCtD
Indomethacin—Headache—Indinavir—acquired immunodeficiency syndrome	7.54e-05	0.000534	CcSEcCtD
Indomethacin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	7.52e-05	0.000533	CcSEcCtD
Indomethacin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	7.45e-05	0.000527	CcSEcCtD
Indomethacin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	7.41e-05	0.000525	CcSEcCtD
Indomethacin—ABCB1—lung—acquired immunodeficiency syndrome	7.4e-05	0.00115	CbGeAlD
Indomethacin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	7.34e-05	0.00052	CcSEcCtD
Indomethacin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	7.3e-05	0.000517	CcSEcCtD
Indomethacin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	7.3e-05	0.000517	CcSEcCtD
Indomethacin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	7.23e-05	0.000512	CcSEcCtD
Indomethacin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	7.22e-05	0.000511	CcSEcCtD
Indomethacin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	7.2e-05	0.00051	CcSEcCtD
Indomethacin—Rash—Efavirenz—acquired immunodeficiency syndrome	7.17e-05	0.000508	CcSEcCtD
Indomethacin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	7.16e-05	0.000507	CcSEcCtD
Indomethacin—Nausea—Indinavir—acquired immunodeficiency syndrome	7.15e-05	0.000506	CcSEcCtD
Indomethacin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	7.14e-05	0.000505	CcSEcCtD
Indomethacin—Headache—Efavirenz—acquired immunodeficiency syndrome	7.12e-05	0.000505	CcSEcCtD
Indomethacin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	7.12e-05	0.000504	CcSEcCtD
Indomethacin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	6.95e-05	0.000492	CcSEcCtD
Indomethacin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	6.92e-05	0.00049	CcSEcCtD
Indomethacin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	6.89e-05	0.000488	CcSEcCtD
Indomethacin—Rash—Delavirdine—acquired immunodeficiency syndrome	6.86e-05	0.000486	CcSEcCtD
Indomethacin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	6.85e-05	0.000485	CcSEcCtD
Indomethacin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	6.85e-05	0.000485	CcSEcCtD
Indomethacin—ABCB1—nervous system—acquired immunodeficiency syndrome	6.85e-05	0.00106	CbGeAlD
Indomethacin—Headache—Delavirdine—acquired immunodeficiency syndrome	6.82e-05	0.000483	CcSEcCtD
Indomethacin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	6.81e-05	0.000482	CcSEcCtD
Indomethacin—Nausea—Efavirenz—acquired immunodeficiency syndrome	6.76e-05	0.000478	CcSEcCtD
Indomethacin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	6.65e-05	0.000471	CcSEcCtD
Indomethacin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	6.63e-05	0.000469	CcSEcCtD
Indomethacin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	6.63e-05	0.000469	CcSEcCtD
Indomethacin—ABCB1—central nervous system—acquired immunodeficiency syndrome	6.59e-05	0.00102	CbGeAlD
Indomethacin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	6.54e-05	0.000463	CcSEcCtD
Indomethacin—Nausea—Delavirdine—acquired immunodeficiency syndrome	6.46e-05	0.000458	CcSEcCtD
Indomethacin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	6.4e-05	0.000454	CcSEcCtD
Indomethacin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	6.4e-05	0.000453	CcSEcCtD
Indomethacin—Rash—Ritonavir—acquired immunodeficiency syndrome	6.34e-05	0.000449	CcSEcCtD
Indomethacin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	6.34e-05	0.000449	CcSEcCtD
Indomethacin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	6.32e-05	0.000448	CcSEcCtD
Indomethacin—Headache—Ritonavir—acquired immunodeficiency syndrome	6.3e-05	0.000446	CcSEcCtD
Indomethacin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	6.16e-05	0.000436	CcSEcCtD
Indomethacin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	6.11e-05	0.000433	CcSEcCtD
Indomethacin—Rash—Saquinavir—acquired immunodeficiency syndrome	6.11e-05	0.000432	CcSEcCtD
Indomethacin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	6.1e-05	0.000432	CcSEcCtD
Indomethacin—Headache—Saquinavir—acquired immunodeficiency syndrome	6.07e-05	0.00043	CcSEcCtD
Indomethacin—CXCL8—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	6.01e-05	0.00148	CbGpPWpGaD
Indomethacin—CXCL8—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	5.99e-05	0.00148	CbGpPWpGaD
Indomethacin—Nausea—Ritonavir—acquired immunodeficiency syndrome	5.98e-05	0.000423	CcSEcCtD
Indomethacin—PPARA—Metabolism—TAT—acquired immunodeficiency syndrome	5.91e-05	0.00146	CbGpPWpGaD
Indomethacin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—acquired immunodeficiency syndrome	5.89e-05	0.00145	CbGpPWpGaD
Indomethacin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	5.87e-05	0.000416	CcSEcCtD
Indomethacin—PTGDR2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	5.84e-05	0.00144	CbGpPWpGaD
Indomethacin—Rash—Lamivudine—acquired immunodeficiency syndrome	5.83e-05	0.000413	CcSEcCtD
Indomethacin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	5.82e-05	0.000412	CcSEcCtD
Indomethacin—AKR1C3—Metabolism—AGPS—acquired immunodeficiency syndrome	5.79e-05	0.00143	CbGpPWpGaD
Indomethacin—Headache—Lamivudine—acquired immunodeficiency syndrome	5.79e-05	0.00041	CcSEcCtD
Indomethacin—PTGDR2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	5.75e-05	0.00142	CbGpPWpGaD
Indomethacin—Nausea—Saquinavir—acquired immunodeficiency syndrome	5.75e-05	0.000407	CcSEcCtD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	5.66e-05	0.0014	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	5.63e-05	0.00139	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—CCNT1—acquired immunodeficiency syndrome	5.53e-05	0.00137	CbGpPWpGaD
Indomethacin—Nausea—Lamivudine—acquired immunodeficiency syndrome	5.49e-05	0.000389	CcSEcCtD
Indomethacin—ABCC4—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	5.39e-05	0.00133	CbGpPWpGaD
Indomethacin—CXCL8—AP-1 transcription factor network—IL6—acquired immunodeficiency syndrome	5.36e-05	0.00132	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	5.31e-05	0.00131	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	5.29e-05	0.00131	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	5.29e-05	0.00131	CbGpPWpGaD
Indomethacin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	5.29e-05	0.00131	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	5.26e-05	0.0013	CbGpPWpGaD
Indomethacin—ABCB1—brain—acquired immunodeficiency syndrome	5.24e-05	0.000811	CbGeAlD
Indomethacin—PPARG—Signaling events mediated by HDAC Class I—TNF—acquired immunodeficiency syndrome	5.24e-05	0.00129	CbGpPWpGaD
Indomethacin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—acquired immunodeficiency syndrome	5.23e-05	0.00129	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	5.23e-05	0.00129	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	5.17e-05	0.00128	CbGpPWpGaD
Indomethacin—PTGS1—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	5.17e-05	0.00128	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—CCNT1—acquired immunodeficiency syndrome	5.17e-05	0.00128	CbGpPWpGaD
Indomethacin—ABCB1—lymph node—acquired immunodeficiency syndrome	5.06e-05	0.000783	CbGeAlD
Indomethacin—CXCL8—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	5.04e-05	0.00125	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—AGPS—acquired immunodeficiency syndrome	5.02e-05	0.00124	CbGpPWpGaD
Indomethacin—ABCC6—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	4.93e-05	0.00122	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	4.92e-05	0.00122	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	4.92e-05	0.00122	CbGpPWpGaD
Indomethacin—CXCL8—Toll-like Receptor Signaling Pathway—TNF—acquired immunodeficiency syndrome	4.92e-05	0.00121	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	4.9e-05	0.00121	CbGpPWpGaD
Indomethacin—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—acquired immunodeficiency syndrome	4.85e-05	0.0012	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.85e-05	0.0012	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	4.79e-05	0.00118	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.78e-05	0.00118	CbGpPWpGaD
Indomethacin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	4.77e-05	0.00118	CbGpPWpGaD
Indomethacin—CXCL8—Glucocorticoid receptor regulatory network—IL6—acquired immunodeficiency syndrome	4.73e-05	0.00117	CbGpPWpGaD
Indomethacin—PTGS1—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	4.72e-05	0.00117	CbGpPWpGaD
Indomethacin—ALB—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	4.69e-05	0.00116	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	4.68e-05	0.00116	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	4.68e-05	0.00116	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.5e-05	0.00111	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—TAT—acquired immunodeficiency syndrome	4.48e-05	0.00111	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—TAT—acquired immunodeficiency syndrome	4.48e-05	0.00111	CbGpPWpGaD
Indomethacin—PPARA—Adipogenesis—TNF—acquired immunodeficiency syndrome	4.45e-05	0.0011	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.38e-05	0.00108	CbGpPWpGaD
Indomethacin—CXCL8—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	4.38e-05	0.00108	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—TAT—acquired immunodeficiency syndrome	4.23e-05	0.00105	CbGpPWpGaD
Indomethacin—SLC22A11—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	4.22e-05	0.00104	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	4.12e-05	0.00102	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	4.12e-05	0.00102	CbGpPWpGaD
Indomethacin—PTGS2—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	4.1e-05	0.00101	CbGpPWpGaD
Indomethacin—PTGS2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	4.07e-05	0.00101	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	4.03e-05	0.000995	CbGpPWpGaD
Indomethacin—CXCL8—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	3.97e-05	0.00098	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—TAT—acquired immunodeficiency syndrome	3.9e-05	0.000963	CbGpPWpGaD
Indomethacin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—IL6—acquired immunodeficiency syndrome	3.88e-05	0.000958	CbGpPWpGaD
Indomethacin—CXCL8—Senescence and Autophagy in Cancer—IL6—acquired immunodeficiency syndrome	3.88e-05	0.000958	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.87e-05	0.000957	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.87e-05	0.000957	CbGpPWpGaD
Indomethacin—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—acquired immunodeficiency syndrome	3.84e-05	0.000948	CbGpPWpGaD
Indomethacin—SLC22A7—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	3.83e-05	0.000946	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	3.81e-05	0.000942	CbGpPWpGaD
Indomethacin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—acquired immunodeficiency syndrome	3.81e-05	0.000941	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—AGPS—acquired immunodeficiency syndrome	3.81e-05	0.000941	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—AGPS—acquired immunodeficiency syndrome	3.81e-05	0.000941	CbGpPWpGaD
Indomethacin—PTGS2—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	3.75e-05	0.000928	CbGpPWpGaD
Indomethacin—PTGS2—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	3.75e-05	0.000925	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—CCNT1—acquired immunodeficiency syndrome	3.7e-05	0.000914	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.65e-05	0.000902	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—TAT—acquired immunodeficiency syndrome	3.64e-05	0.000899	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—TAT—acquired immunodeficiency syndrome	3.64e-05	0.000899	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.64e-05	0.000899	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	3.63e-05	0.000896	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—AGPS—acquired immunodeficiency syndrome	3.6e-05	0.000889	CbGpPWpGaD
Indomethacin—PPARA—Adipogenesis—IL6—acquired immunodeficiency syndrome	3.59e-05	0.000888	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—IFNA1—acquired immunodeficiency syndrome	3.55e-05	0.000877	CbGpPWpGaD
Indomethacin—CXCL8—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	3.53e-05	0.000872	CbGpPWpGaD
Indomethacin—ABCC4—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	3.51e-05	0.000868	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—TAT—acquired immunodeficiency syndrome	3.51e-05	0.000867	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.5e-05	0.000865	CbGpPWpGaD
Indomethacin—CXCL8—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	3.5e-05	0.000865	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—IL2—acquired immunodeficiency syndrome	3.39e-05	0.000837	CbGpPWpGaD
Indomethacin—ABCC1—Disease—APOBEC3G—acquired immunodeficiency syndrome	3.35e-05	0.000827	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—TAT—acquired immunodeficiency syndrome	3.33e-05	0.000824	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	3.32e-05	0.000819	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.27e-05	0.000807	CbGpPWpGaD
Indomethacin—SLC22A8—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	3.22e-05	0.000795	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	3.2e-05	0.000789	CbGpPWpGaD
Indomethacin—PPARG—Adipogenesis—TNF—acquired immunodeficiency syndrome	3.19e-05	0.000788	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	3.18e-05	0.000786	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.13e-05	0.000774	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.1e-05	0.000767	CbGpPWpGaD
Indomethacin—CXCL8—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	3.1e-05	0.000765	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—AGPS—acquired immunodeficiency syndrome	3.09e-05	0.000764	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—AGPS—acquired immunodeficiency syndrome	3.09e-05	0.000764	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.09e-05	0.000763	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.06e-05	0.000755	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.06e-05	0.000755	CbGpPWpGaD
Indomethacin—PTGS1—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	3.05e-05	0.000754	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	3.04e-05	0.000751	CbGpPWpGaD
Indomethacin—ALB—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	3.03e-05	0.00075	CbGpPWpGaD
Indomethacin—ALB—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	3.03e-05	0.000749	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.99e-05	0.000739	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.99e-05	0.000739	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.98e-05	0.000737	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	2.98e-05	0.000736	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—TAT—acquired immunodeficiency syndrome	2.97e-05	0.000733	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	2.96e-05	0.000732	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—CXCR4—acquired immunodeficiency syndrome	2.91e-05	0.000718	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	2.89e-05	0.000715	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.89e-05	0.000714	CbGpPWpGaD
Indomethacin—SLCO1A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.86e-05	0.000706	CbGpPWpGaD
Indomethacin—ABCC4—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	2.85e-05	0.000704	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CCNT1—acquired immunodeficiency syndrome	2.85e-05	0.000704	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.84e-05	0.0007	CbGpPWpGaD
Indomethacin—CXCL8—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	2.82e-05	0.000698	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.82e-05	0.000698	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—CSF2—acquired immunodeficiency syndrome	2.78e-05	0.000686	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.76e-05	0.000683	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.76e-05	0.000682	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.72e-05	0.000671	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.72e-05	0.000671	CbGpPWpGaD
Indomethacin—SLC22A6—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.69e-05	0.000663	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.67e-05	0.000659	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	2.63e-05	0.00065	CbGpPWpGaD
Indomethacin—PPARG—Adipogenesis—IL6—acquired immunodeficiency syndrome	2.57e-05	0.000636	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	2.57e-05	0.000635	CbGpPWpGaD
Indomethacin—PPARA—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.54e-05	0.000626	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.52e-05	0.000623	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—TNF—acquired immunodeficiency syndrome	2.47e-05	0.00061	CbGpPWpGaD
Indomethacin—PTGS1—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	2.46e-05	0.000609	CbGpPWpGaD
Indomethacin—CXCL8—Cellular Senescence—IL6—acquired immunodeficiency syndrome	2.45e-05	0.000606	CbGpPWpGaD
Indomethacin—ALB—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	2.45e-05	0.000605	CbGpPWpGaD
Indomethacin—SLCO1B1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.44e-05	0.000604	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	2.44e-05	0.000603	CbGpPWpGaD
Indomethacin—PTGS2—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	2.42e-05	0.000599	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.39e-05	0.000591	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—TAT—acquired immunodeficiency syndrome	2.35e-05	0.000582	CbGpPWpGaD
Indomethacin—PPARA—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.31e-05	0.000572	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.28e-05	0.000562	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APOBEC3G—acquired immunodeficiency syndrome	2.25e-05	0.000555	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.24e-05	0.000554	CbGpPWpGaD
Indomethacin—PPARA—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.2e-05	0.000543	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.16e-05	0.000535	CbGpPWpGaD
Indomethacin—SLC22A11—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.14e-05	0.00053	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.07e-05	0.000511	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.05e-05	0.000507	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.04e-05	0.000503	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.03e-05	0.000503	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.03e-05	0.000503	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AGPS—acquired immunodeficiency syndrome	2e-05	0.000495	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—IL6—acquired immunodeficiency syndrome	1.99e-05	0.000492	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—CCR5—acquired immunodeficiency syndrome	1.99e-05	0.000492	CbGpPWpGaD
Indomethacin—ALB—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	1.96e-05	0.000485	CbGpPWpGaD
Indomethacin—PTGS2—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	1.96e-05	0.000483	CbGpPWpGaD
Indomethacin—SLC22A7—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.95e-05	0.000481	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	1.92e-05	0.000474	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CCNT1—acquired immunodeficiency syndrome	1.91e-05	0.000472	CbGpPWpGaD
Indomethacin—ALB—Metabolism—TAT—acquired immunodeficiency syndrome	1.91e-05	0.000471	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.89e-05	0.000466	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	1.87e-05	0.000463	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.86e-05	0.00046	CbGpPWpGaD
Indomethacin—CXCL8—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	1.85e-05	0.000458	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	1.82e-05	0.000449	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—ALB—acquired immunodeficiency syndrome	1.81e-05	0.000447	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.75e-05	0.000433	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—TAT—acquired immunodeficiency syndrome	1.71e-05	0.000422	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.71e-05	0.000422	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	1.67e-05	0.000412	CbGpPWpGaD
Indomethacin—ABCC3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.67e-05	0.000412	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.66e-05	0.00041	CbGpPWpGaD
Indomethacin—SLC22A8—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.63e-05	0.000404	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.63e-05	0.000403	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—ALB—acquired immunodeficiency syndrome	1.63e-05	0.000402	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.62e-05	0.000401	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AGPS—acquired immunodeficiency syndrome	1.62e-05	0.0004	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—IFNA1—acquired immunodeficiency syndrome	1.61e-05	0.000397	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.61e-05	0.000397	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.61e-05	0.000397	CbGpPWpGaD
Indomethacin—ALB—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	1.58e-05	0.000391	CbGpPWpGaD
Indomethacin—ABCC4—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.57e-05	0.000387	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	1.56e-05	0.000385	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.55e-05	0.000382	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	1.55e-05	0.000382	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—TNF—acquired immunodeficiency syndrome	1.53e-05	0.000378	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.53e-05	0.000377	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.52e-05	0.000377	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CXCR4—acquired immunodeficiency syndrome	1.5e-05	0.00037	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—IL2—acquired immunodeficiency syndrome	1.47e-05	0.000363	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AGPS—acquired immunodeficiency syndrome	1.45e-05	0.000359	CbGpPWpGaD
Indomethacin—SLCO1A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.45e-05	0.000359	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.42e-05	0.000352	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.42e-05	0.000351	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.39e-05	0.000345	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—ALB—acquired immunodeficiency syndrome	1.38e-05	0.000341	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.37e-05	0.000339	CbGpPWpGaD
Indomethacin—SLC22A6—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.36e-05	0.000337	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	1.33e-05	0.000328	CbGpPWpGaD
Indomethacin—ABCC2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.32e-05	0.000327	CbGpPWpGaD
Indomethacin—ABCC1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.31e-05	0.000323	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.31e-05	0.000323	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.3e-05	0.000322	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	1.29e-05	0.000318	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—CSF2—acquired immunodeficiency syndrome	1.26e-05	0.000311	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—CD4—acquired immunodeficiency syndrome	1.25e-05	0.000309	CbGpPWpGaD
Indomethacin—SLCO1B1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.24e-05	0.000307	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—IL6—acquired immunodeficiency syndrome	1.23e-05	0.000305	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.22e-05	0.000302	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.2e-05	0.000297	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—ALB—acquired immunodeficiency syndrome	1.19e-05	0.000294	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.18e-05	0.000293	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.16e-05	0.000287	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.1e-05	0.000272	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—TNF—acquired immunodeficiency syndrome	1.1e-05	0.000271	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.08e-05	0.000266	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—ALB—acquired immunodeficiency syndrome	1.03e-05	0.000255	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CCR5—acquired immunodeficiency syndrome	1.03e-05	0.000253	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CXCR4—acquired immunodeficiency syndrome	1e-05	0.000248	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9.59e-06	0.000237	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	9.24e-06	0.000228	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.22e-06	0.000228	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—IL6—acquired immunodeficiency syndrome	8.85e-06	0.000219	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.06e-06	0.000199	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—ALB—acquired immunodeficiency syndrome	7.81e-06	0.000193	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—ALB—acquired immunodeficiency syndrome	7.81e-06	0.000193	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—ALB—acquired immunodeficiency syndrome	7.38e-06	0.000182	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CCR5—acquired immunodeficiency syndrome	6.88e-06	0.00017	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—ALB—acquired immunodeficiency syndrome	6.8e-06	0.000168	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—IL6—acquired immunodeficiency syndrome	6.76e-06	0.000167	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	6.7e-06	0.000165	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—IL2—acquired immunodeficiency syndrome	6.64e-06	0.000164	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CD4—acquired immunodeficiency syndrome	6.44e-06	0.000159	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.36e-06	0.000157	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—ALB—acquired immunodeficiency syndrome	6.35e-06	0.000157	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ALB—acquired immunodeficiency syndrome	6.35e-06	0.000157	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.32e-06	0.000156	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.21e-06	0.000154	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ALB—acquired immunodeficiency syndrome	6.12e-06	0.000151	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	6.11e-06	0.000151	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ALB—acquired immunodeficiency syndrome	5.81e-06	0.000144	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ALB—acquired immunodeficiency syndrome	5.17e-06	0.000128	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.74e-06	0.000117	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CD4—acquired immunodeficiency syndrome	4.32e-06	0.000107	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ALB—acquired immunodeficiency syndrome	4.11e-06	0.000101	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.74e-06	9.23e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6—acquired immunodeficiency syndrome	3.48e-06	8.6e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	2.98e-06	7.37e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	2.91e-06	7.19e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	2.72e-06	6.72e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6—acquired immunodeficiency syndrome	2.34e-06	5.77e-05	CbGpPWpGaD
